Statement Of Changes In Net Assets

Cytori Cell Research Institute,Inc. - Filing #7246462

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
As at
2023-03-31
Statement of changes in net assets
Statement of changes in net assets
Net assets
211,501,000 JPY
-1,530,000 JPY
5,567,965,000 JPY
2,445,118,000 JPY
JPY
JPY
-190,584,000 JPY
100,000,000 JPY
419,035,000 JPY
JPY
-1,530,000 JPY
100,000,000 JPY
2,939,075,000 JPY
3,122,846,000 JPY
-5,857,019,000 JPY
18,286,000 JPY
-2,618,510,000 JPY
-5,875,306,000 JPY
630,536,000 JPY
20,917,000 JPY
211,501,000 JPY
211,501,000 JPY
4,791,000 JPY
100,000,000 JPY
2,977,762,000 JPY
2,445,118,000 JPY
-1,485,000 JPY
-2,688,717,000 JPY
276,000 JPY
2,939,268,000 JPY
18,286,000 JPY
-458,765,000 JPY
-2,707,003,000 JPY
5,567,965,000 JPY
-1,485,000 JPY
3,122,846,000 JPY
100,000,000 JPY
2,795,586,000 JPY
2,579,016,000 JPY
211,501,000 JPY
276,000 JPY
3,189,263,000 JPY
211,501,000 JPY
66,000 JPY
1,074,424,000 JPY
18,286,000 JPY
100,000,000 JPY
100,000,000 JPY
1,056,137,000 JPY
3,122,846,000 JPY
2,441,106,000 JPY
6,952,650,000 JPY
66,000 JPY
2,939,268,000 JPY
5,567,965,000 JPY
-1,240,000 JPY
-1,240,000 JPY
4,007,000 JPY
2,445,118,000 JPY
2,656,682,000 JPY
6,741,149,000 JPY
-596,921,000 JPY
211,501,000 JPY
Changes during period
Profit (loss)
JPY
-3,168,302,000 JPY
-3,168,302,000 JPY
-3,168,302,000 JPY
-2,140,294,000 JPY
-3,168,302,000 JPY
-3,763,141,000 JPY
-3,763,141,000 JPY
-3,763,141,000 JPY
-3,763,141,000 JPY
JPY
138,939,000 JPY
Total changes during period
JPY
JPY
-276,000 JPY
JPY
-276,000 JPY
-44,000 JPY
-44,000 JPY
JPY
JPY
-4,791,000 JPY
JPY
-3,168,302,000 JPY
-3,168,346,000 JPY
-3,168,346,000 JPY
-2,159,981,000 JPY
JPY
-2,165,049,000 JPY
-2,159,744,000 JPY
-3,168,302,000 JPY
JPY
-193,000 JPY
783,000 JPY
JPY
-3,763,141,000 JPY
137,910,000 JPY
JPY
JPY
JPY
JPY
-3,763,386,000 JPY
-3,763,386,000 JPY
JPY
-245,000 JPY
210,000 JPY
-3,763,141,000 JPY
210,000 JPY
138,155,000 JPY
JPY
138,903,000 JPY
-245,000 JPY
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.